DEXORYL ΩΤΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΕΝΑΙΩΡΗΜΑ ΓΙΑ ΣΚΥΛΟΥΣ ΚΑΙ ΓΑΤΕΣ
DEXORYL ΩΤΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΕΝΑΙΩΡΗΜΑ ΓΙΑ ΣΚΥΛΟΥΣ ΚΑΙ ΓΑΤΕΣ
Not authorised
- Gentamicin sulfate
- Tiabendazole
- Dexamethasone
Product identification
Medicine name:
DEXORYL ΩΤΙΚΕΣ ΣΤΑΓΟΝΕΣ, ΕΝΑΙΩΡΗΜΑ ΓΙΑ ΣΚΥΛΟΥΣ ΚΑΙ ΓΑΤΕΣ
Active substance:
- Gentamicin sulfate
- Tiabendazole
- Dexamethasone
Target species:
-
Dog
-
Cat
Route of administration:
-
Auricular use
Product details
Active substance and strength:
-
Gentamicin sulfate300.00/milligram(s)100.00gram(s)
-
Tiabendazole4.00/gram(s)100.00gram(s)
-
Dexamethasone90.30/milligram(s)100.00gram(s)
Pharmaceutical form:
-
Ear drops, suspension
Withdrawal period by route of administration:
-
Auricular use
-
Dog
-
Not applicableno withdrawal period
-
-
Cat
-
Not applicableno withdrawal period
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QS02
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Greece
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Complete application (stand-alone)
Marketing authorisation holder:
- Virbac
Marketing authorisation date:
Manufacturing sites for batch release:
- Virbac
Responsible authority:
- National Organization For Medicines
Authorisation number:
- 750/09-01-2013/K-0087001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet